Rocket Lab (NASDAQ:RKLB) SVP Sells $402,166.10 in Stock

Key Points

• Rocket Lab SVP Arjun Kampani sold 6,034 shares for $402,166 at an average price of $66.65 under a pre-arranged Rule 10b5-1 plan, reducing his ownership by 2.35% to 250,917 shares.
• Rocket Lab shares fell to $64.39, while the company reported a quarterly loss of $0.08 per share—worse than analysts’ expected $0.06 loss—despite revenue of $234.07 million exceeding estimates.
• Analysts maintain a broadly positive outlook, with a “Moderate Buy” consensus and average price target of $110.65, although Rocket Lab remains unprofitable and faces valuation and execution risks.

Rocket Lab Corporation (NASDAQ:RKLB - Get Free Report) SVP Arjun Kampani sold 6,034 shares of Rocket Lab stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $66.65, for a total value of $402,166.10. Following the completion of the sale, the senior vice president owned 250,917 shares in the company, valued at approximately $16,723,618.05. This trade represents a 2.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Arjun Kampani also recently made the following trade(s):

• On Monday, August 24th, Arjun Kampani sold 7,754 shares of Rocket Lab stock. The stock was sold at an average price of $69.63, for a total value of $539,911.02.
• On Thursday, June 18th, Arjun Kampani sold 88,000 shares of Rocket Lab stock. The shares were sold at an average price of $107.98, for a total value of $9,502,240.00.

Rocket Lab Price Performance

Shares of NASDAQ RKLB traded down $3.14 during trading on Friday, hitting $64.39. 18,486,456 shares of the company were exchanged, compared to its average volume of 23,476,473. The company has a market cap of $38.53 billion, a price-to-earnings ratio of -238.47 and a beta of 2.60. Rocket Lab Corporation has a 1 year low of $37.57 and a 1 year high of $151.00. The firm's fifty day moving average price is $78.66 and its 200 day moving average price is $85.12. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.48 and a quick ratio of 4.98.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). The company had revenue of $234.07 million for the quarter, compared to analyst estimates of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. On average, sell-side analysts expect that Rocket Lab Corporation will post -0.2 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on RKLB shares. KeyCorp reaffirmed an "overweight" rating on shares of Rocket Lab in a report on Tuesday, August 11th. Cantor Fitzgerald boosted their price target on Rocket Lab from $96.00 to $122.00 and gave the stock an "overweight" rating in a research note on Tuesday, August 11th. Wall Street Zen cut Rocket Lab from a "hold" rating to a "sell" rating in a report on Saturday, August 15th. Deutsche Bank Aktiengesellschaft raised their price objective on Rocket Lab from $73.00 to $120.00 and gave the company a "buy" rating in a research note on Tuesday, May 12th. Finally, Stifel Nicolaus set a $132.00 target price on Rocket Lab in a research report on Thursday, June 4th. Three analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $110.65.

Institutional Trading of Rocket Lab

Several institutional investors and hedge funds have recently modified their holdings of the business. Mcguire Capital Advisors Inc. acquired a new stake in shares of Rocket Lab in the fourth quarter valued at approximately $27,000. Zions Bancorporation National Association UT acquired a new position in shares of Rocket Lab in the fourth quarter worth $28,000. EverSource Wealth Advisors LLC lifted its position in shares of Rocket Lab by 109.5% in the second quarter. EverSource Wealth Advisors LLC now owns 796 shares of the rocket manufacturer's stock valued at $28,000 after acquiring an additional 416 shares in the last quarter. Gordian Capital Singapore Pte Ltd acquired a new stake in shares of Rocket Lab during the fourth quarter valued at $29,000. Finally, Reflection Asset Management acquired a new stake in shares of Rocket Lab during the fourth quarter valued at $30,000. Hedge funds and other institutional investors own 71.78% of the company's stock.

Rocket Lab News Summary

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Defense and space-systems demand remain important growth drivers. Rocket Lab is benefiting from its selection by Viasat to build spacecraft buses for the U.S. Space Force’s Protected Tactical SATCOM-Global program. Its HASTE hypersonic test platform is also expanding the company’s exposure to Pentagon missions, supporting the view that Rocket Lab is more than an Electron launch provider. Rocket Lab HASTE defense coverage
• Positive Sentiment: Electron execution and analyst revisions offer potential support. Rocket Lab has reached 93 Electron launches, while some analysts have raised earnings estimates. A hammer chart pattern has also prompted bottom-fishing interest after the decline. Rocket Lab bottom-fisher coverage
• Neutral Sentiment: Analysts remain broadly bullish, but the valuation requires strong execution. Rocket Lab carries a reported “Moderate Buy” consensus and an average price target of $110.65, but the company remains unprofitable and trades at a high valuation relative to current earnings. Its elevated beta also leaves the stock vulnerable to sharp swings.
• Negative Sentiment: Neutron timing is the largest operational risk. Reports that the medium-lift Neutron rocket’s first launch could slip into 2027 have weakened a key investment thesis. The delay would postpone a major revenue and valuation catalyst while extending development costs. Rocket Lab Neutron timeline coverage
• Negative Sentiment: Insider selling adds to near-term pressure. Five executives sold approximately $5.5 million of shares, including sizable sales by the CFO and COO. The transactions were made under Rule 10b5-1 plans to cover tax withholding on vested restricted stock units, reducing their significance, though no comparable insider buying was reported. Rocket Lab executive sale coverage
• Negative Sentiment: Profitability remains a concern. Rocket Lab’s latest quarterly revenue exceeded expectations, but its $0.08-per-share loss was wider than forecast. Continued annual losses make the stock particularly sensitive to acquisition uncertainty, Neutron delays, and any slowdown in launch or defense growth.

About Rocket Lab

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source